Skip to main content
Top
Published in:

Open Access 01-12-2024 | Iron Deficiency | Research

Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study

Authors: Reiko Okubo, Tomohiro Ohigashi, Masahide Kondo, Ryoya Tsunoda, Hirayasu Kai, Chie Saito, Junichi Hoshino, Hirokazu Okada, Ichiei Narita, Shoichi Maruyama, Takashi Wada, Kunihiro Yamagata

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Iron deficiency is a major contributor to anaemia in chronic kidney diseases. The association of anaemia and iron deficiency with health-related quality of life in Japanese patients with non-dialysis chronic kidney disease has not been examined. In this study, we evaluated anaemia and iron deficiency in patients with chronic kidney disease G3b-5 and examined their associations with health-related quality of life.

Methods

This nationwide cohort study included 2,249 patients with advanced chronic kidney disease receiving nephrologist care from 31 representative facilities throughout Japan; they were randomly selected through stratification by region and facility size and aligned with the Chronic Kidney Disease Outcomes and Practice Patterns Study. Using baseline patient data, we assessed the association of anaemia and iron deficiency with health-related quality of life, employing the 36-item Kidney Disease Quality of Life Questionnaire.

Results

The mean mental and physical component summary scores for all patients were 49 and 47, respectively. Patients with haemoglobin levels < 10 g/dL had worse three kidney disease subscale, mental component summary, physical component summary, and subdomain scores than those with haemoglobin levels > 12 g/dL. Patients with absolute iron deficiency (TSAT < 20% and ferritin < 100 ng/mL) had worse three kidney disease subscale and mental component summary scores than those with functional iron deficiency (TSAT < 20% and ferritin ≥ 100 ng/mL).

Conclusions

Japanese patients with chronic kidney disease G3b-5 with anaemia or absolute iron deficiency had worse health-related quality of life. Our results provide clinical evidence of renal anaemia in Japan and will be useful for international comparisons.
Literature
1.
go back to reference Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Nephrology (Carlton). 2015;20:601–8.CrossRefPubMed Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Nephrology (Carlton). 2015;20:601–8.CrossRefPubMed
2.
go back to reference Akizawa T, Okumura H, Alexandre AF, Fukushima A, Kiyabu G, Dorey J. Burden of anemia in chronic kidney disease patients in Japan: A literature review. Ther Apher Dial. 2018;22:444–56.CrossRefPubMed Akizawa T, Okumura H, Alexandre AF, Fukushima A, Kiyabu G, Dorey J. Burden of anemia in chronic kidney disease patients in Japan: A literature review. Ther Apher Dial. 2018;22:444–56.CrossRefPubMed
3.
go back to reference Wong MMY, Tu C, Li Y, Perlman RL, Pecoits-Filho R, Lopes AA, et al. Anemia and iron deficiency among chronic kidney disease stages 3–5ND patients in the chronic kidney disease outcomes and practice patterns study: Often unmeasured, variably treated. Clin Kidney J. 2020;13:613–24.CrossRefPubMed Wong MMY, Tu C, Li Y, Perlman RL, Pecoits-Filho R, Lopes AA, et al. Anemia and iron deficiency among chronic kidney disease stages 3–5ND patients in the chronic kidney disease outcomes and practice patterns study: Often unmeasured, variably treated. Clin Kidney J. 2020;13:613–24.CrossRefPubMed
4.
go back to reference Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020;31:456–68.CrossRefPubMedPubMedCentral Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020;31:456–68.CrossRefPubMedPubMedCentral
5.
go back to reference Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: Conclusions from a kidney disease: Improving global outcomes (KDIGO) conference. Kidney Int, Conference Participants. 2021;99:1280–95.CrossRef Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, et al. Controversies in optimal anemia management: Conclusions from a kidney disease: Improving global outcomes (KDIGO) conference. Kidney Int, Conference Participants. 2021;99:1280–95.CrossRef
6.
go back to reference Kuragano T, Okami S, Tanaka-Mizuno S, Uenaka H, Kimura T, Ishida Y, et al. Anemia treatment, hemoglobin variability, and clinical events in patients with nondialysis-dependent CKD in Japan. Kidney360. 2023;4:e1223–35.CrossRefPubMedPubMedCentral Kuragano T, Okami S, Tanaka-Mizuno S, Uenaka H, Kimura T, Ishida Y, et al. Anemia treatment, hemoglobin variability, and clinical events in patients with nondialysis-dependent CKD in Japan. Kidney360. 2023;4:e1223–35.CrossRefPubMedPubMedCentral
7.
go back to reference Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC. An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic veterans with predialysis chronic kidney disease. Kidney Int. 2019;96:750–60.CrossRefPubMed Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC. An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic veterans with predialysis chronic kidney disease. Kidney Int. 2019;96:750–60.CrossRefPubMed
8.
go back to reference Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, et al. Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol. 2021;32:2020–30.CrossRefPubMedPubMedCentral Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, et al. Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol. 2021;32:2020–30.CrossRefPubMedPubMedCentral
9.
go back to reference Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021;36:129–36.CrossRefPubMed Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021;36:129–36.CrossRefPubMed
10.
go back to reference Hasegawa T, Imaizumi T, Hamano T, Murotani K, Fujii N, Komaba H, et al. Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease. Nephrol Dial Transplant. 2023;38:2713–22.CrossRefPubMedPubMedCentral Hasegawa T, Imaizumi T, Hamano T, Murotani K, Fujii N, Komaba H, et al. Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease. Nephrol Dial Transplant. 2023;38:2713–22.CrossRefPubMedPubMedCentral
11.
go back to reference Guedes M, Muenz D, Zee J, Lopes MB, Waechter S, Stengel B, et al. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia. Nephrol Dial Transplant. 2021;36:1694–703.CrossRefPubMedPubMedCentral Guedes M, Muenz D, Zee J, Lopes MB, Waechter S, Stengel B, et al. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia. Nephrol Dial Transplant. 2021;36:1694–703.CrossRefPubMedPubMedCentral
13.
go back to reference Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al. Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant. 2013;28:1346–59.CrossRefPubMed Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al. Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant. 2013;28:1346–59.CrossRefPubMed
14.
go back to reference Ku E, Del Vecchio L, Eckardt KU, Haase VH, Johansen KL, Nangaku M, et al. Novel anemia therapies in chronic kidney disease: Conclusions from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int, for Conference Participants. 2023;104:655–80.CrossRef Ku E, Del Vecchio L, Eckardt KU, Haase VH, Johansen KL, Nangaku M, et al. Novel anemia therapies in chronic kidney disease: Conclusions from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney Int, for Conference Participants. 2023;104:655–80.CrossRef
15.
go back to reference 2015. JSDT guideline for renal anemia in chronic kidney disease (in Japanese). J Jpn Soc Dial Ther 2016;49:89–158. 2015. JSDT guideline for renal anemia in chronic kidney disease (in Japanese). J Jpn Soc Dial Ther 2016;49:89–158.
16.
go back to reference Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.CrossRef Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.CrossRef
17.
go back to reference Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2023 (in Japanese). Tokyo-Igakusha. 2023. Japanese Society of Nephrology. Evidence-based clinical practice guideline for CKD 2023 (in Japanese). Tokyo-Igakusha. 2023.
18.
go back to reference Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, et al. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The reach-J CKD cohort study. Clin Exp Nephrol. 2018;22:309–17.CrossRefPubMed Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, et al. A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The reach-J CKD cohort study. Clin Exp Nephrol. 2018;22:309–17.CrossRefPubMed
19.
go back to reference Hoshino J, Tsunoda R, Nagai K, Kai H, Saito C, Ito Y, et al. Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b–5: Results from a REACH-J CKD cohort study. Clin Exp Nephrol. 2021;25:902–10.CrossRefPubMed Hoshino J, Tsunoda R, Nagai K, Kai H, Saito C, Ito Y, et al. Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b–5: Results from a REACH-J CKD cohort study. Clin Exp Nephrol. 2021;25:902–10.CrossRefPubMed
20.
go back to reference Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, et al. The CKD outcomes and practice patterns study (CKDopps): Rationale and methods. Am J Kidney Dis. 2016;68:402–13.CrossRefPubMed Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, et al. The CKD outcomes and practice patterns study (CKDopps): Rationale and methods. Am J Kidney Dis. 2016;68:402–13.CrossRefPubMed
21.
go back to reference Ware JJ, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed Ware JJ, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
22.
go back to reference Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–38.CrossRefPubMed Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–38.CrossRefPubMed
23.
go back to reference Okubo R, Kondo M, Tsunoda R, Nagai K, Kai H, Saito C, et al. Physical functioning in patients with chronic kidney disease stage G3b–5 in Japan: The reach-J CKD cohort study. Nephrology (Carlton). 2021;26:981–7.CrossRefPubMed Okubo R, Kondo M, Tsunoda R, Nagai K, Kai H, Saito C, et al. Physical functioning in patients with chronic kidney disease stage G3b–5 in Japan: The reach-J CKD cohort study. Nephrology (Carlton). 2021;26:981–7.CrossRefPubMed
24.
go back to reference Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3–5 nondialysis CKD. J Ren Nutr. 2020;30:404–14.CrossRefPubMed Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3–5 nondialysis CKD. J Ren Nutr. 2020;30:404–14.CrossRefPubMed
26.
go back to reference Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis. 2006;3:A118.PubMedPubMedCentral Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis. 2006;3:A118.PubMedPubMedCentral
27.
go back to reference van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: Analysis of multinational real-world data. BMC Nephrol. 2020;21:88.CrossRefPubMedPubMedCentral van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: Analysis of multinational real-world data. BMC Nephrol. 2020;21:88.CrossRefPubMedPubMedCentral
28.
go back to reference Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:33–8.CrossRefPubMedPubMedCentral Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:33–8.CrossRefPubMedPubMedCentral
29.
go back to reference Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–98.CrossRefPubMed Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–98.CrossRefPubMed
30.
go back to reference Johansen KL, Cobitz AR, Singh AK, Macdougall IC, Lopes RD, Obrador GT, et al. The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease. Kidney Int. 2023;103:1180–92.CrossRefPubMed Johansen KL, Cobitz AR, Singh AK, Macdougall IC, Lopes RD, Obrador GT, et al. The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease. Kidney Int. 2023;103:1180–92.CrossRefPubMed
Metadata
Title
Associations of anaemia and iron deficiency with health-related quality of life in patients with chronic kidney disease stage G3b-5 in Japan: sub analysis of the Reach-J CKD cohort study
Authors
Reiko Okubo
Tomohiro Ohigashi
Masahide Kondo
Ryoya Tsunoda
Hirayasu Kai
Chie Saito
Junichi Hoshino
Hirokazu Okada
Ichiei Narita
Shoichi Maruyama
Takashi Wada
Kunihiro Yamagata
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03849-8

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more